KELSIE WATSON: Open Payments
NPI 1235842576 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$503 in 20 payments from 8 companies in 2025. Trend: 2023 $537 · 2024 $951 · 2025 $503
Food & beverage: $503
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 5 | $136 |
| Novartis Pharmaceuticals Corporation | 3 | $124 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $116 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $59 |
| PFIZER INC. | 1 | $21 |
| Novo Nordisk Inc | 1 | $17 |
| SCPHARMACEUTICALS INC. | 1 | $14 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: VERQUVO, LEQVIO, JARDIANCE, LifeVest, VYNDAQEL, Wegovy, FUROSCIX, CAMZYOS.
Industry payments across IN — which companies pay providers there.
